XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Equity Award Programs
Common Stock
Common Stock
Equity Award Programs
Common stock and additional paid-in capital
Common stock and additional paid-in capital
Equity Award Programs
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance, shares at Dec. 31, 2022     72.9          
Beginning balance at Dec. 31, 2022 $ 657       $ 1,206   $ (542) $ (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.2        
Issuance of common stock   $ 1       $ 1    
Stock-based compensation 19       19      
Other comprehensive income (loss) 3             3
Net loss (80)           (80)  
Ending balance, shares at Mar. 31, 2023     73.1          
Ending balance at Mar. 31, 2023 600       1,226   (622) (4)
Beginning balance, shares at Dec. 31, 2022     72.9          
Beginning balance at Dec. 31, 2022 657       1,206   (542) (7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (155)              
Ending balance, shares at Jun. 30, 2023     74.5          
Ending balance at Jun. 30, 2023 566       1,267   (697) (4)
Beginning balance, shares at Mar. 31, 2023     73.1          
Beginning balance at Mar. 31, 2023 600       1,226   (622) (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     1.0 0.4        
Issuance of common stock 20 3     20 3    
Stock-based compensation 18       18      
Net loss (75)           (75)  
Ending balance, shares at Jun. 30, 2023     74.5          
Ending balance at Jun. 30, 2023 $ 566       1,267   (697) (4)
Beginning balance, shares at Dec. 31, 2023 75.5   75.5          
Beginning balance at Dec. 31, 2023 $ 462       1,311   (849) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     15.2 0.2        
Issuance of common stock 228 2     228 2    
Stock-based compensation 20       20      
Other comprehensive income (loss) (1)             (1)
Net loss (4)           (4)  
Ending balance, shares at Mar. 31, 2024     90.9          
Ending balance at Mar. 31, 2024 $ 707       1,561   (853) (1)
Beginning balance, shares at Dec. 31, 2023 75.5   75.5          
Beginning balance at Dec. 31, 2023 $ 462       1,311   (849) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss $ (97)              
Ending balance, shares at Jun. 30, 2024 91.3   91.3          
Ending balance at Jun. 30, 2024 $ 635       1,582   (946) (1)
Beginning balance, shares at Mar. 31, 2024     90.9          
Beginning balance at Mar. 31, 2024 707       1,561   (853) (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.4        
Issuance of common stock   $ 1       $ 1    
Stock-based compensation 20       20      
Net loss $ (93)           (93)  
Ending balance, shares at Jun. 30, 2024 91.3   91.3          
Ending balance at Jun. 30, 2024 $ 635       $ 1,582   $ (946) $ (1)